Does CHARLES RIVER LABORATORIES INTERNATIONAL, INC. have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) 35.2 out of 100 — below the Shallow-moat bar, so no moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 46, pricing power 100, returns on capital 18, balance-sheet safety 0, capital allocation 12.

Is CRL trading below the conservative owner-earnings estimate?

The value if growth stopped today — a zero-growth baseline — is $96.57 per share. It capitalizes normalized owner earnings at a 9% rate and assumes 0% growth. Versus a recent price of $226.58, that is 135% above value if growth stopped today. The model also publishes a capped-growth comparison, but the zero-growth estimate is the cautious baseline. It assumes trailing owner earnings persist and is unreliable for declining businesses. This is an educational estimate from primary SEC filings, not intrinsic value as a fact or investment advice.

How has CRL's Moat Score changed over time?

The record logs 16 readings since Jul 17, 2026; the latest reads 35.2 out of 100 (no moat). No tier changes on record yet. (Methodology or normalizer upgrades on Jul 20, 2026, Jul 23, 2026, Jul 26, 2026 re-based the score; readings across versions aren't compared.) The history is append-only — readings are only ever added, never rewritten.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL · Consumer Discretionary · $11.2B mkt cap · FY2025 filings · as of Jul 26, 2026 · not refreshed in 36 days · No moat ·

Doesn't clear the bar

No moat

The five investor questions

2021–2025 (latest 5 aligned FYs; v3 window cap 5): revenue $3.5B to $4.0B, increasing; diluted EPS 7.60 to -2.91, decreasing.

100

Median gross margin 84.0% over 2y, very stable.

Median ROIC 9.0%, above the 12% hurdle in 0% of years.

Net debt/EBITDA 4.5x, interest coverage 0x.

Owner earnings changed -17.5%/yr over up to the ten most recent annual observations.

Price vs. value if growth stopped today

A cautious baseline, not a price target: what the shares may support if normalized owner earnings simply hold steady.

Above value if growth stopped todayBelow value if growth stopped today

135% above value if growth stopped today

: $428M
: $96.57
: $96.57
: $226.58
: 135% above value if growth stopped today

What today’s price assumes: owner earnings growing ~19%/yr over 5 years. The zero-growth estimate assumes owner earnings stay flat (0% growth).

How to read this

We solve for the constant annual change in owner earnings that would make the five-year zero-growth estimate equal today’s price. This keeps the existing model inputs and calculation unchanged; it is an expectations lens, not a forecast.

This zero-growth estimate assumes trailing owner earnings persist — unreliable for declining businesses. The recent FY revenue series does not trigger the three-consecutive-declines flag.

Among the current top-score group, the median current price is 239% above the zero-growth estimate across 48 of the current top 50 companies by Moat Score with both values.

Score records captured Jul 26, 2026.

Exactly which 50 companies?

FTNT, META, MEDP, IBEX, MSFT, GOOGL, LULU, ANF, IDXX, TXRH, FHI, QLYS, FFIV, ADBE, LLY, MANH, VEEV, GRMN, SSD, MNST, DOCS, MCO, CPRT, NTAP, LRCX, NVDA, CORT, SFM, MPTI, ULTA, SN, RMD, ROL, PAYC, IRMD, INTU, DECK, MORN, LGCY, DAL, GWW, ISRG, MPWR, CTAS, LOPE, MRK, CMG, FAST, BKNG, ORLY

Missing a usable price or zero-growth estimate: ANF, BKNG.

Model details under moat-index@3.0.0: zero-growth multiple 11.1×, capped-growth comparison at no more than 18×; 9% discount rate; high-end growth 0% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.

19 years of fundamentals

The business, in plain English

Across the filed record, revenue grew from $1.3B (FY2008) to $4.0B (FY2025) — about 6.9% a year compounded over 17 years.

It earned 0.4% on invested capital in the latest filed year, FY2025. Across the full 18-year measurable filed record, median ROIC was 9.3%. Over the v3 recent window (10 measurable filed years), median ROIC was 9.0%. The Returns on Capital filter above scores it 18/100.

The balance sheet carried $2.1B of total debt in FY2025 against $39.8M of owner earnings — roughly 53.7 years of owner earnings to retire it all. Balance-Sheet Safety scores it 0/100.

Put together: Pricing Power is the strongest of the five filters (100/100) and Balance-Sheet Safety the weakest (0/100), which is how CRL lands at 35/100 — a None moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

Sales, as filed$4.0B FY2025

Revenue kept after cost of goods84.4% FY2017

Standard ROIC or separately labeled Operating ROICROIC 0.4% FY2025

Cash an owner could take out$39.8M FY2025

Gaps in a line mean that item isn’t in CRL’s filings for that year. The series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Flagship explainer

How CHARLES RIVER LABORATORIES INTERNATIONAL, INC. makes its money

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s filing does not supply enough comparable lines for a truthful flow chart — here's what is filed:

Table alternative
Filed line	Value	% of revenue	Source
	$4.0B	100%	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
	$25.2M	1%	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
Income before tax	−$99.5M	−2%	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
Income tax	$42.7M	1%	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
	−$144M	−4%	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022

Source:

SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022

· event Dec 27, 2025 · retrieved Jul 26, 2026 · annual-row source set

Flagship explainer

What CHARLES RIVER LABORATORIES INTERNATIONAL, INC. owns — and owes

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s filing tags don't support a full breakdown — here's what is filed:

Table alternative
Filed line	Value	% of assets	Source
Total assets	$7.1B	100%	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
Cash and equivalents	$214M	3%	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
	$2.1B	30%	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
Stockholders’ equity	$3.2B	44%	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022

Source:

SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022

· event Dec 27, 2025 · retrieved Jul 26, 2026 · annual-row source set

Flagship explainer

What drives CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont source inputs
Input	Value	Fiscal year	Source
	−$144M	FY2025	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
Income before tax	−$99.5M	FY2025	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
Operating income	$25.2M	FY2025	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
	$4.0B	FY2025	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
Ending assets	$7.1B	FY2025	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
Beginning assets	$7.5B	FY2024	SEC filing · FY 2024Filing detailsAccession 0001100682-26-000022
	$3.2B	FY2025	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
	$3.5B	FY2024	SEC filing · FY 2024Filing detailsAccession 0001100682-26-000022

Source:

SEC filingFiling detailsAccession 0001100682-26-000022

· event Dec 27, 2025 · retrieved Jul 26, 2026 · annual-row source set

Embed this chart

Flagship explainer

Where CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s cash went

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s filing does not supply enough provenance-matched cash-flow lines for a truthful flow chart — here’s what is filed:

Table alternative
Filed line	Value	% of cash from operations	Source
Cash from operations	$738M	100%	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022
Depreciation and amortization	$403M	55%	SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022

Source:

SEC filing · FY 2025Filing detailsAccession 0001100682-26-000022

· event Dec 27, 2025 · retrieved Jul 26, 2026 · annual-row source set

Curated 19-manager tier

Who reported holding CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Delayed public 13F reports for 2026-Q2—not live positions, trades, or recommendations.

0 holding0 exited1 not holding1/19 resolved18 not retrieved

Named manager positions and quarter-over-quarter changes
Manager	Reported position	Quarter-over-quarter	Filing accession
Markel / Markel-Gayner	No position reported	No position reported	13F-HR · Q1 2026Filing detailsAccession 0001096343-26-000044 · filed May 1, 2026 13F-HR · Q2 2026Filing detailsAccession 0001096343-26-000065 · filed Jul 31, 2026
Abrams Capital	Not retrieved	Comparison not retrieved	Filing not retrieved
Akre Capital	Not retrieved	Comparison not retrieved	Filing not retrieved
Baupost Group	Not retrieved	Comparison not retrieved	Filing not retrieved
Berkshire Hathaway	Not retrieved	Comparison not retrieved	Filing not retrieved
Brave Warrior Advisors	Not retrieved	Comparison not retrieved	Filing not retrieved
Dodge & Cox	Not retrieved	Comparison not retrieved	Filing not retrieved
First Eagle	Not retrieved	Comparison not retrieved	Filing not retrieved
Fundsmith	Not retrieved	Comparison not retrieved	Filing not retrieved
Gardner Russo & Quinn	Not retrieved	Comparison not retrieved	Filing not retrieved
Gates Foundation Trust	Not retrieved	Comparison not retrieved	Filing not retrieved
Mairs & Power	Not retrieved	Comparison not retrieved	Filing not retrieved
Oakmark / Harris Associates	Not retrieved	Comparison not retrieved	Filing not retrieved
Pershing Square	Not retrieved	Comparison not retrieved	Filing not retrieved
Polen Capital	Not retrieved	Comparison not retrieved	Filing not retrieved
Sequoia / Ruane Cunniff	Not retrieved	Comparison not retrieved	Filing not retrieved
Southeastern Asset Management	Not retrieved	Comparison not retrieved	Filing not retrieved
Tweedy, Browne	Not retrieved	Comparison not retrieved	Filing not retrieved
Yacktman Asset Management	Not retrieved	Comparison not retrieved	Filing not retrieved

Position size uses shares and filed value from each manager’s 13F. Portfolio weight uses the eligible long-share filing denominator. Changes compare only with the immediately preceding calendar quarter.

Source:

13F-HR · Q1 2026Filing detailsAccession 0001096343-26-000044 · filed May 1, 2026
13F-HR · Q2 2026Filing detailsAccession 0001096343-26-000065 · filed Jul 31, 2026

· event Jun 30, 2026 · retrieved Jul 26, 2026

Flagship explainer

What CHARLES RIVER LABORATORIES INTERNATIONAL, INC. insiders reported

Records still being gathered — partial as of retrieval Aug 31, 2026.

Partial coverage: the incomplete Form 4 walk cannot establish no activity, an activity date, or zero counts.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale35.2 / 100

Breaks in the line mark methodology or normalizer upgrades — readings across versions aren’t compared, so a level shift there isn’t a change in the business.

Tier changesSame-methodology and same-normalizer crossings of the Wide / Narrow / Shallow bars

Normalizer upgraded unstamped (version unknown)tomoat-xbrl-normalizer@1.1.0 — readings across versions aren’t comparedJul 26, 2026
Methodology upgraded moat-index@2.0.0tomoat-index@3.0.0 — readings across versions aren’t comparedJul 23, 2026
Methodology upgraded moat-index@1.2.0tomoat-index@2.0.0 — readings across versions aren’t comparedJul 20, 2026

Scores are logged append-only and never overwritten — this record cannot be reconstructed retroactively, which is exactly why it’s worth keeping.

Insider activity

Form 4 reports mix P/S market or private transactions with compensation-plan mechanics. Activity casually described as “insider selling” can include compensation mechanics; awards, tax withholding, and option exercises are shown by their exact filed class here, never collapsed into “Bought” or “Sold.”

These are disclosed filing facts and arithmetic aggregates, not a signal or verdict.

This machine-readable surface covers SEC ownership filings from 2003; it does not represent earlier paper-era records.

Records still being gathered — partial as of retrieval Aug 31, 2026.

68 filings were skipped because the SEC primary document returned 404; the omission is disclosed and aggregates are withheld.

Among the rows shown, A/F/M acquisition, payment or withholding, and exercise or conversion rows outnumber S sale rows (22 versus 17). The filing codes alone do not establish that every such row arose from a compensation plan.

Trailing-12-month totals and the 90-day cluster result are withheld because this issuer walk is incomplete.

Insider					Shares owned after	Date	Filing detail
FOSTER JAMES CDirector	Exercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 2 paired events	33,561	$199.4233	$6,692,845	See lot detail	Aug 25, 2026	2 filed lots Table I · Common Stock: 21,132 shares at $194.12 · code M · owned after 52,728 · Paired event: 21,132 Stock Options (Right to Buy) → 21,132 Common Stock · FORM 4 · filed Aug 27, 2026Filing detailsAccession 0001100682-26-000140 · filed Aug 27, 2026 Table I · Common Stock: 12,429 shares at $208.44 · code M · owned after 65,157 · Paired event: 12,429 Stock Options (Right to Buy) → 12,429 Common Stock · FORM 4 · filed Aug 27, 2026Filing detailsAccession 0001100682-26-000140 · filed Aug 27, 2026
FOSTER JAMES CDirector	Open-market or private sale (S)Table I · Disposed · Common Stock	33,561	$300.00	$10,068,300	31,596	Aug 25, 2026	1 filed lot Table I · Common Stock: 33,561 shares at $300.00 · code S · owned after 31,596 · FORM 4 · filed Aug 27, 2026Filing detailsAccession 0001100682-26-000140 · filed Aug 27, 2026
FOSTER JAMES CDirector	Exercise or conversion of derivative security (M)Table II · Disposed · Stock Options (Right to Buy) · 2 paired events	33,561	—Exercise or conversion of derivative security (M)	—	See lot detail	Aug 25, 2026	2 filed lots Table II · Stock Options (Right to Buy): 21,132 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 7,044 · Paired event: 21,132 Stock Options (Right to Buy) → 21,132 Common Stock · FORM 4 · filed Aug 27, 2026Filing detailsAccession 0001100682-26-000140 · filed Aug 27, 2026 Table II · Stock Options (Right to Buy): 12,429 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 12,429 · Paired event: 12,429 Stock Options (Right to Buy) → 12,429 Common Stock · FORM 4 · filed Aug 27, 2026Filing detailsAccession 0001100682-26-000140 · filed Aug 27, 2026
Girshick BirgitDirector, Chief Executive Officer	Gift (G)Table I · Disposed · Common Stock	528	—Gift (G)	—	35,485	Aug 19, 2026	1 filed lot Table I · Common Stock: 528 shares at — (Gift (G)) · code G · owned after 35,485 · FORM 4 · filed Aug 20, 2026Filing detailsAccession 0001100682-26-000138 · filed Aug 20, 2026
Parisotto Shannon MCEVP, Disc & Safety Assessment	Exercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 1 paired event	2,039	$194.12	$395,811	6,846	Aug 19, 2026	1 filed lot Table I · Common Stock: 2,039 shares at $194.12 · code M · owned after 6,846 · Paired event: 2,039 Stock Options (Right to Buy) → 2,039 Common Stock · FORM 4 · filed Aug 20, 2026Filing detailsAccession 0001100682-26-000136 · filed Aug 20, 2026
Parisotto Shannon MCEVP, Disc & Safety Assessment	Open-market or private sale (S)Table I · Disposed · Common Stock	2,039	$294.12	$599,711	4,807	Aug 19, 2026	1 filed lot Table I · Common Stock: 2,039 shares at $294.12 · code S · owned after 4,807 · FORM 4 · filed Aug 20, 2026Filing detailsAccession 0001100682-26-000136 · filed Aug 20, 2026
Parisotto Shannon MCEVP, Disc & Safety Assessment	Exercise or conversion of derivative security (M)Table II · Disposed · Stock Options (Right to Buy) · 1 paired event	2,039	—Exercise or conversion of derivative security (M)	—	2,039	Aug 19, 2026	1 filed lot Table II · Stock Options (Right to Buy): 2,039 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 2,039 · Paired event: 2,039 Stock Options (Right to Buy) → 2,039 Common Stock · FORM 4 · filed Aug 20, 2026Filing detailsAccession 0001100682-26-000136 · filed Aug 20, 2026
Andrews Nancy CDirector	Exercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 1 paired event	573	$164.30	$94,144	2,011	Aug 18, 2026	1 filed lot Table I · Common Stock: 573 shares at $164.30 · code M · owned after 2,011 · Paired event: 573 Stock Options (Right to Buy) → 573 Common Stock · FORM 4 · filed Aug 20, 2026Filing detailsAccession 0001100682-26-000134 · filed Aug 20, 2026
Andrews Nancy CDirector	Open-market or private sale (S)Table I · Disposed · Common Stock	573	$285.24	$163,443	1,438	Aug 18, 2026	1 filed lot Table I · Common Stock: 573 shares at $285.24 · code S · owned after 1,438 · FORM 4 · filed Aug 20, 2026Filing detailsAccession 0001100682-26-000134 · filed Aug 20, 2026
Andrews Nancy CDirector	Exercise or conversion of derivative security (M)Table II · Disposed · Stock Options (Right to Buy) · 1 paired event	573	—Exercise or conversion of derivative security (M)	—	0	Aug 18, 2026	1 filed lot Table II · Stock Options (Right to Buy): 573 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 0 · Paired event: 573 Stock Options (Right to Buy) → 573 Common Stock · FORM 4 · filed Aug 20, 2026Filing detailsAccession 0001100682-26-000134 · filed Aug 20, 2026
Girshick BirgitDirector, Chief Executive Officer	Exercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 1 paired event	6,500	$179.66	$1,167,790	42,513	Aug 11, 2026	1 filed lot Table I · Common Stock: 6,500 shares at $179.66 · code M · owned after 42,513 · Paired event: 6,500 Stock Options (Right to Buy) → 6,500 Common Stock · FORM 4 · filed Aug 13, 2026Filing detailsAccession 0001100682-26-000132 · filed Aug 13, 2026
Girshick BirgitDirector, Chief Executive Officer	Open-market or private sale (S)Table I · Disposed · Common Stock	6,500	$279.90	$1,819,350	36,013	Aug 11, 2026	1 filed lot Table I · Common Stock: 6,500 shares at $279.90 · code S · owned after 36,013 · FORM 4 · filed Aug 13, 2026Filing detailsAccession 0001100682-26-000132 · filed Aug 13, 2026
Girshick BirgitDirector, Chief Executive Officer	Exercise or conversion of derivative security (M)Table II · Disposed · Stock Options (Right to Buy) · 1 paired event	6,500	—Exercise or conversion of derivative security (M)	—	0	Aug 11, 2026	1 filed lot Table II · Stock Options (Right to Buy): 6,500 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 0 · Paired event: 6,500 Stock Options (Right to Buy) → 6,500 Common Stock · FORM 4 · filed Aug 13, 2026Filing detailsAccession 0001100682-26-000132 · filed Aug 13, 2026
Parisotto Shannon MCEVP, Disc & Safety Assessment	Exercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 1 paired event	3,714	$179.66	$667,257	8,521	Aug 11, 2026	1 filed lot Table I · Common Stock: 3,714 shares at $179.66 · code M · owned after 8,521 · Paired event: 3,714 Stock Options (Right to Buy) → 3,714 Common Stock · FORM 4 · filed Aug 13, 2026Filing detailsAccession 0001100682-26-000130 · filed Aug 13, 2026
Parisotto Shannon MCEVP, Disc & Safety Assessment	Open-market or private sale (S)Table I · Disposed · Common Stock	3,714	$279.66	$1,038,657	4,807	Aug 11, 2026	1 filed lot Table I · Common Stock: 3,714 shares at $279.66 · code S · owned after 4,807 · FORM 4 · filed Aug 13, 2026Filing detailsAccession 0001100682-26-000130 · filed Aug 13, 2026
Parisotto Shannon MCEVP, Disc & Safety Assessment	Exercise or conversion of derivative security (M)Table II · Disposed · Stock Options (Right to Buy) · 1 paired event	3,714	—Exercise or conversion of derivative security (M)	—	0	Aug 11, 2026	1 filed lot Table II · Stock Options (Right to Buy): 3,714 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 0 · Paired event: 3,714 Stock Options (Right to Buy) → 3,714 Common Stock · FORM 4 · filed Aug 13, 2026Filing detailsAccession 0001100682-26-000130 · filed Aug 13, 2026
LaPlume Joseph WEVP, Corp Strategy & Develop	Gift (G)Table I · Disposed · Common Stock	257	—Gift (G)	—	31,041	Aug 10, 2026	1 filed lot Table I · Common Stock: 257 shares at — (Gift (G)) · code G · owned after 31,041 · FORM 4 · filed Aug 11, 2026Filing detailsAccession 0001100682-26-000128 · filed Aug 11, 2026
FOSTER JAMES CDirector	Exercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 1 paired event	28,733	$179.66	$5,162,171	60,329	Aug 10, 2026	1 filed lot Table I · Common Stock: 28,733 shares at $179.66 · code M · owned after 60,329 · Paired event: 28,733 Stock Options (Right to Buy) → 28,733 Common Stock · FORM 4 · filed Aug 11, 2026Filing detailsAccession 0001100682-26-000126 · filed Aug 11, 2026
FOSTER JAMES CDirector	Open-market or private sale (S)Table I · Disposed · Common Stock	28,733	$275.00	$7,901,575	31,596	Aug 10, 2026	1 filed lot Table I · Common Stock: 28,733 shares at $275.00 · code S · owned after 31,596 · FORM 4 · filed Aug 11, 2026Filing detailsAccession 0001100682-26-000126 · filed Aug 11, 2026
FOSTER JAMES CDirector	Exercise or conversion of derivative security (M)Table II · Disposed · Stock Options (Right to Buy) · 1 paired event	28,733	—Exercise or conversion of derivative security (M)	—	0	Aug 10, 2026	1 filed lot Table II · Stock Options (Right to Buy): 28,733 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 0 · Paired event: 28,733 Stock Options (Right to Buy) → 28,733 Common Stock · FORM 4 · filed Aug 11, 2026Filing detailsAccession 0001100682-26-000126 · filed Aug 11, 2026
Knell Michael GunnarSVP, Finance and CAO	Open-market or private sale (S)Table I · Disposed · Common Stock	6,645	$260.3837	$1,730,250	See lot detail	Aug 6, 2026	9 filed lots Table I · Common Stock: 1,274 shares at $259.07 · code S · owned after 14,878 · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table I · Common Stock: 901 shares at $260.63 · code S · owned after 13,977 · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table I · Common Stock: 1,205 shares at $258.53 · code S · owned after 12,588 · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table I · Common Stock: 736 shares at $258.53 · code S · owned after 11,852 · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table I · Common Stock: 810 shares at $261.45 · code S · owned after 13,167 · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table I · Common Stock: 213 shares at $262.37 · code S · owned after 12,954 · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table I · Common Stock: 620 shares at $263.94 · code S · owned after 12,334 · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table I · Common Stock: 482 shares at $265.17 · code S · owned after 11,852 · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table I · Common Stock: 404 shares at $258.53 · code S · owned after 13,793 · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026
Knell Michael GunnarSVP, Finance and CAO	Exercise or conversion of derivative security (M)Table II · Disposed · Stock Options (Right to Buy) · 3 paired events	2,345	—Exercise or conversion of derivative security (M)	—	See lot detail	Aug 6, 2026	3 filed lots Table II · Stock Options (Right to Buy): 404 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 0 · Paired event: 404 Stock Options (Right to Buy) → 404 Common Stock · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table II · Stock Options (Right to Buy): 1,205 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 402 · Paired event: 1,205 Stock Options (Right to Buy) → 1,205 Common Stock · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table II · Stock Options (Right to Buy): 736 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 736 · Paired event: 736 Stock Options (Right to Buy) → 736 Common Stock · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026
Knell Michael GunnarSVP, Finance and CAO	Exercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 3 paired events	2,345	$196.1233	$459,909	See lot detail	Aug 6, 2026	3 filed lots Table I · Common Stock: 404 shares at $179.66 · code M · owned after 12,256 · Paired event: 404 Stock Options (Right to Buy) → 404 Common Stock · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table I · Common Stock: 1,205 shares at $194.12 · code M · owned after 13,461 · Paired event: 1,205 Stock Options (Right to Buy) → 1,205 Common Stock · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026 Table I · Common Stock: 736 shares at $208.44 · code M · owned after 14,197 · Paired event: 736 Stock Options (Right to Buy) → 736 Common Stock · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000124 · filed Aug 10, 2026
Creamer Victoria LEVP & Chief People Officer	Exercise or conversion of derivative security (M)Table I · Acquired · Common Stock · 1 paired event	4,179	$179.66	$750,799	34,230	Aug 6, 2026	1 filed lot Table I · Common Stock: 4,179 shares at $179.66 · code M · owned after 34,230 · Paired event: 4,179 Stock Options (Right to Buy) → 4,179 Common Stock · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000122 · filed Aug 10, 2026
Creamer Victoria LEVP & Chief People Officer	Open-market or private sale (S)Table I · Disposed · Common Stock	4,179	$259.16	$1,083,030	30,051	Aug 6, 2026	1 filed lot Table I · Common Stock: 4,179 shares at $259.16 · code S · owned after 30,051 · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000122 · filed Aug 10, 2026
Creamer Victoria LEVP & Chief People Officer	Exercise or conversion of derivative security (M)Table II · Disposed · Stock Options (Right to Buy) · 1 paired event	4,179	—Exercise or conversion of derivative security (M)	—	0	Aug 6, 2026	1 filed lot Table II · Stock Options (Right to Buy): 4,179 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 0 · Paired event: 4,179 Stock Options (Right to Buy) → 4,179 Common Stock · FORM 4 · filed Aug 10, 2026Filing detailsAccession 0001100682-26-000122 · filed Aug 10, 2026
Parisotto Shannon MCEVP, Disc & Safety Assessment	Open-market or private sale (S)Table I · Disposed · Common Stock	5,046	$263.00	$1,327,098	4,807	Aug 5, 2026	1 filed lot Table I · Common Stock: 5,046 shares at $263.00 · code S · owned after 4,807 · FORM 4 · filed Aug 6, 2026Filing detailsAccession 0001100682-26-000120 · filed Aug 6, 2026

Source-event as of Aug 25, 2026. Retrieved Aug 31, 2026.

Track record

How CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s moat rated in each of the years we can reconstruct from its filings — scored only on what was knowable at the time — and what its price and returns did afterward. The score never saw a price; the two are joined only in hindsight, for education, not as a signal.

Point-in-time Moat Score (dot colored by tier)Indexed price (total-return (dividends reinvested))Rated Wide-moat that year

How to read this: each dot is what the engine would have scored CRL on that December 31; the line below is its total-return price path (dividends reinvested) in the years since.

Two tracks, one timeline: the score has its own 0–100 scale (top), the price its own 100-based scale (bottom) — never a shared axis. The price path is a total-return (dividends reinvested) index built from the same data the forward returns use; gaps in the score line are years with no reconstructed rating (see the table for why). The Table view carries every value.

What followed, in the years it rated Wide

In the reconstructed history shown, CRL did not rate Wide-moat in any year, so there is no wide-moat track record to report. That absence is itself the honest answer — we don’t manufacture a comparison where the rating never earned one.

Consumer Discretionary context

#351 of 487 scored Consumer Discretionary companies, ranked by Moat Score.

Nearest peers by Moat Score

#349UAA UNDER ARMOUR, INC.35.3 out of 100, No moatNo moat
#350WH Wyndham Hotels & Resorts, Inc.35.3 out of 100, No moatNo moat
#352BODI The Beachbody Company, Inc.35.2 out of 100, No moatNo moat
#353SGC SUPERIOR GROUP OF COMPANIES, INC.34.9 out of 100, No moatNo moat

Compare CRL with its nearest peers →All Consumer Discretionary companies on the Index →

Common questions about CRL

Does CHARLES RIVER LABORATORIES INTERNATIONAL, INC. have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) 35.2 out of 100 — below the Shallow-moat bar, so no moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 46, pricing power 100, returns on capital 18, balance-sheet safety 0, capital allocation 12.
Is CRL trading below the conservative owner-earnings estimate?: The value if growth stopped today — a zero-growth baseline — is $96.57 per share. It capitalizes normalized owner earnings at a 9% rate and assumes 0% growth. Versus a recent price of $226.58, that is 135% above value if growth stopped today. The model also publishes a capped-growth comparison, but the zero-growth estimate is the cautious baseline. It assumes trailing owner earnings persist and is unreliable for declining businesses. This is an educational estimate from primary SEC filings, not intrinsic value as a fact or investment advice.
How has CRL's Moat Score changed over time?: The record logs 16 readings since Jul 17, 2026; the latest reads 35.2 out of 100 (no moat). No tier changes on record yet. (Methodology or normalizer upgrades on Jul 20, 2026, Jul 23, 2026, Jul 26, 2026 re-based the score; readings across versions aren't compared.) The history is append-only — readings are only ever added, never rewritten.

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell CRL. See the disclaimer.